Prolactinomas [3] (multiple letters)

New England Journal of Medicine

Volumn 350, Issue 10, 2004, Pages 1054-1057

  Friedman, Theodore C ^a   Couldwell, William T ^b   Weiss, Martin H ^c   Laws Jr , Edward R ^d   Hortin, Glen L ^e   Colao, Annamaria ^f   Lombardi, Gaetano ^f   Schlechte, Janet ^g  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

^f UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^g UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CABERGOLINE; PROLACTIN; ANTINEOPLASTIC AGENT; ERGOLINE DERIVATIVE; PROLACTIN, POLYMERIC;

DRUG EFFICACY; HUMAN; HYPERPROLACTINEMIA; LETTER; PRIORITY JOURNAL; PROLACTINOMA; TREATMENT INDICATION; BLOOD; HYPOPHYSIS TUMOR; NOTE; TREATMENT WITHDRAWAL; DIAGNOSIS, MEASUREMENT AND ANALYSIS;

ANTINEOPLASTIC AGENTS; ERGOLINES; HUMANS; HYPERPROLACTINEMIA; PITUITARY NEOPLASMS; PROLACTIN; PROLACTINOMA; WITHHOLDING TREATMENT; LABORATORY TECHNIQUES AND PROCEDURES;

EID: 1442306231     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200403043501019     Document Type: Letter

References (0)